SecureCHEK AI Earns SOC 2 Type II Recertification
In the pharmaceutical and medical device industries, security, privacy, and regulatory compliance aren't just checkboxes, they're mission critical. That's why we're proud to announce that SecureCHEK AI has successfully recertified for SOC 2 Type II.
What Recertification Actually Means
A SOC 2 Type II report isn't a one-time snapshot. It's an independent auditor's evaluation of a company's internal controls, covering security, availability, processing integrity, confidentiality, and privacy tested continuously over an audit period, not just verified once and forgotten.
Recertifying means we didn't just pass this test once. Cycle after cycle, we continue to demonstrate that our security practices hold up under sustained, independent scrutiny and not as a moment-in-time achievement, but as a discipline we maintain every day, on every release, for every customer.
Security Is a Practice, Not a Milestone
A SOC 2 badge earned once and never revisited tells you what a company's controls looked like at a single point in time. Recertification tells you something different: that the organization has built security into how it actually operates — quarterly access reviews, continuous vulnerability scanning, encrypted data at rest and in transit, monitored infrastructure, and a change-management process that gets re-tested against the same rigorous standard, cycle after cycle.
That's the commitment behind SOC 2 Type II, and it's the commitment we're renewing today: not a certificate on the wall, but an operating standard we hold ourselves to continuously.
Why This Matters More in Pharma and Medtech Than Almost Anywhere Else
Companies in regulated life sciences are entrusting vendors with promotional content, medical affairs submissions, and workflow data that carries real regulatory weight. When you're choosing a technology partner to sit inside that process, "trust us" isn't good enough, you need independent, ongoing verification.
Here's the part worth saying plainly: not every vendor in this space has this. Many technology partners serving pharma and medtech either haven't pursued a SOC 2 attestation at all, or completed one once, early on, and never talk about it again. If a vendor can't point to a current, recurring SOC 2 Type II report, that's a legitimate question to ask them directly, and a meaningful point of differentiation for those of us who can.
Our Message to the Industry
When evaluating technology suppliers, don't just ask whether they take security seriously, ask them to prove it, on a recurring basis, through independent attestation. A current SOC 2 Type II report (or equivalent) isn't just a badge; it's evidence of daily operating discipline, and it will materially speed up your own internal security review process when you're ready to move forward.
This recertification is a testament to the trust our customers place in us, and our ongoing promise to uphold the highest standards of security and compliance — not just today, but on every audit cycle going forward.
A huge thank you to our team and partners who helped us reach this milestone. Onward, toward even higher standards of integrity and innovation.
Curious what a compliant, audit-ready MLR review process actually looks like? Take our free MLR Bottleneck Self-Assessment to see where your current process stands.